GlassScriptPhysician profile
Richard T Laughlin
NPI 1811954555
$6,172.04
in general payments reported to CMS, 2019-2025
11 companies · $790 in 2025
The $790 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,022 · 2021: $2,127 · 2022: $298 · 2023: $1,045 · 2024: $891 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,725.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,349.68 | 2019-2025 | Gamma, Infinity Adaptis, Inbone |
| Legacy Ortho LLC | $1,200.00 | 2021 | |
| Smith+Nephew, INC. | $947.02 | 2019-2025 | Trigen Intertan, Evos, Q-Fix |
| Medical Device Business Services, INC. | $748.51 | 2019-2024 | |
| Depuy Synthes Sales INC. | $329.59 | 2021-2025 | Expert Nail, Na, Symphony |
| Wright Medical Technology, INC. | $167.47 | 2019 | |
| Paragon 28, INC. | $163.00 | 2021-2023 | Additive Orthopedics |
| Encore Medical, LP | $117.93 | 2022 | |
| Zimmer Biomet Holdings, INC. | $89.11 | 2019 | |
| Restor3d, INC. | $34.08 | 2024 | |
| Orthofix Medical, INC. | $25.65 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Laughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.